000 | 01267 a2200313 4500 | ||
---|---|---|---|
005 | 20250512035337.0 | ||
264 | 0 | _c19880726 | |
008 | 198807s 0 0 eng d | ||
022 | _a0934-9723 | ||
024 | 7 |
_a10.1007/BF01962182 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHobbs, M | |
245 | 0 | 0 |
_aEvaluation of in vitro antifungal activity of LY121019. _h[electronic resource] |
260 |
_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cFeb 1988 |
||
300 |
_a77-80 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aAmphotericin B _xpharmacology |
650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
650 | 0 | 4 |
_aCandida _xdrug effects |
650 | 0 | 4 |
_aCandida albicans _xdrug effects |
650 | 0 | 4 | _aEchinocandins |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPeptides _xpharmacology |
650 | 0 | 4 | _aPeptides, Cyclic |
700 | 1 | _aPerfect, J | |
700 | 1 | _aDurack, D | |
773 | 0 |
_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 7 _gno. 1 _gp. 77-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01962182 _zAvailable from publisher's website |
999 |
_c3138183 _d3138183 |